Adenoid cystic carcinoma

4 trials 1 recruiting MedDRA PT
4 Registered trials
1 Recruiting
4 Unique sponsors
0 Unique IMPs
3 Commercial trials
Drug classes (ATC)
— ATC code not specified 4
Phase I: 3 Phase I (Other): 1

Filter these 4 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 4 trials

Phase I

3 trials
  • Immunocore Limited Commercial
    IMP not specified
    2023-509767-25-00 3 countries 2024 n=520
    Recruiting
  • Remix Therapeutics Inc. Commercial
    IMP not specified
    2023-508476-11-00 1 country n=30
    Pending
  • Seagen Inc. Commercial
    IMP not specified
    2023-503389-22-00 4 countries 2022 n=147
    Ended

Phase I (Other)

1 trial
  • Groupe Oncologie Radiotherapie Tete Cou Academic
    IMP not specified
    2023-503270-20-00 1 country 2023 n=32
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Immunocore Limited Commercial 1 Phase I 1
Remix Therapeutics Inc. Commercial 1 Phase I 0
Seagen Inc. Commercial 1 Phase I 0
Groupe Oncologie Radiotherapie Tete Cou Academic 1 Phase I (Other) 0
New trials by year
2022
1
2023
1
2024
1
← All indication landscapes